BNP Paribas Financial Markets’s Theravance Biopharma TBPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.27M | Buy |
387,472
+91,300
| +31% | +$1.01M | ﹤0.01% | 1453 |
|
|
2025
Q1 | $2.64M | Sell |
296,172
-9,443
| -3% | -$84.3K | ﹤0.01% | 1536 |
|
|
2024
Q4 | $2.88M | Buy |
305,615
+135
| +0% | +$1.27K | ﹤0.01% | 1505 |
|
|
2024
Q3 | $2.46M | Buy |
305,480
+143,781
| +89% | +$1.16M | ﹤0.01% | 1342 |
|
|
2024
Q2 | $1.37M | Buy |
161,699
+128,241
| +383% | +$1.09M | ﹤0.01% | 1520 |
|
|
2024
Q1 | $300K | Buy |
33,458
+7,851
| +31% | +$70.4K | ﹤0.01% | 2457 |
|
|
2023
Q4 | $288K | Buy |
25,607
+11,813
| +86% | +$133K | ﹤0.01% | 2383 |
|
|
2023
Q3 | $119K | Sell |
13,794
-2,488
| -15% | -$21.5K | ﹤0.01% | 2609 |
|
|
2023
Q2 | $169K | Sell |
16,282
-2,922
| -15% | -$30.2K | ﹤0.01% | 2459 |
|
|
2023
Q1 | $208K | Sell |
19,204
-24,397
| -56% | -$265K | ﹤0.01% | 2508 |
|
|
2022
Q4 | $489K | Buy |
43,601
+27,644
| +173% | +$310K | ﹤0.01% | 1964 |
|
|
2022
Q3 | $162K | Sell |
15,957
-92,693
| -85% | -$940K | ﹤0.01% | 2879 |
|
|
2022
Q2 | $984K | Sell |
108,650
-15,584
| -13% | -$141K | ﹤0.01% | 1663 |
|
|
2022
Q1 | $1.19M | Buy |
124,234
+47,509
| +62% | +$454K | ﹤0.01% | 1709 |
|
|
2021
Q4 | $848K | Buy |
76,725
+65,935
| +611% | +$729K | ﹤0.01% | 2123 |
|
|
2021
Q3 | $79.8K | Buy |
10,790
+8,717
| +421% | +$64.5K | ﹤0.01% | 2771 |
|
|
2021
Q2 | $30.1K | Sell |
2,073
-4,955
| -71% | -$71.9K | ﹤0.01% | 2832 |
|
|
2021
Q1 | $143K | Sell |
7,028
-2,721
| -28% | -$55.5K | ﹤0.01% | 2635 |
|
|
2020
Q4 | $173K | Sell |
9,749
-1,255
| -11% | -$22.3K | ﹤0.01% | 2317 |
|
|
2020
Q3 | $163K | Buy |
11,004
+7,953
| +261% | +$118K | ﹤0.01% | 2255 |
|
|
2020
Q2 | $64K | Sell |
3,051
-12,880
| -81% | -$270K | ﹤0.01% | 2324 |
|
|
2020
Q1 | $368K | Buy |
15,931
+9,802
| +160% | +$227K | ﹤0.01% | 1965 |
|
|
2019
Q4 | $159K | Sell |
6,129
-1,750
| -22% | -$45.3K | ﹤0.01% | 2423 |
|
|
2019
Q3 | $153K | Buy |
7,879
+2,088
| +36% | +$40.7K | ﹤0.01% | 2276 |
|
|
2019
Q2 | $94.6K | Sell |
5,791
-4,174
| -42% | -$68.2K | ﹤0.01% | 2459 |
|
|
2019
Q1 | $226K | Buy |
9,965
+8,951
| +883% | +$203K | ﹤0.01% | 2057 |
|
|
2018
Q4 | $25.9K | Sell |
1,014
-1,363
| -57% | -$34.9K | ﹤0.01% | 2339 |
|
|
2018
Q3 | $77.7K | Buy |
2,377
+180
| +8% | +$5.88K | ﹤0.01% | 2226 |
|
|
2018
Q2 | $49.8K | Sell |
2,197
-6,863
| -76% | -$156K | ﹤0.01% | 2482 |
|
|
2018
Q1 | $220K | Buy |
9,060
+395
| +5% | +$9.58K | ﹤0.01% | 2189 |
|
|
2017
Q4 | $242K | Buy |
8,665
+3,797
| +78% | +$106K | ﹤0.01% | 2232 |
|
|
2017
Q3 | $167K | Sell |
4,868
-283
| -5% | -$9.69K | ﹤0.01% | 2220 |
|
|
2017
Q2 | $205K | Buy |
5,151
+4,383
| +571% | +$175K | ﹤0.01% | 2094 |
|
|
2017
Q1 | $28.3K | Sell |
768
-1,925
| -71% | -$70.9K | ﹤0.01% | 2452 |
|
|
2016
Q4 | $85.9K | Sell |
2,693
-315
| -10% | -$10K | ﹤0.01% | 2203 |
|
|
2016
Q3 | $109K | Buy |
3,008
+1,577
| +110% | +$57.2K | ﹤0.01% | 2059 |
|
|
2016
Q2 | $32.5K | Buy |
+1,431
| New | +$32.5K | ﹤0.01% | 2433 |
|
|
2016
Q1 | – | Sell |
-6,202
| Closed | -$102K | – | 3039 |
|
|
2015
Q4 | $102K | Buy |
6,202
+983
| +19% | +$16.1K | ﹤0.01% | 2321 |
|
|
2015
Q3 | $57.4K | Buy |
5,219
+2,938
| +129% | +$32.3K | ﹤0.01% | 2761 |
|
|
2015
Q2 | $29.7K | Buy |
2,281
+1,721
| +307% | +$22.4K | ﹤0.01% | 2808 |
|
|
2015
Q1 | $9.72K | Buy |
+560
| New | +$9.72K | ﹤0.01% | 2758 |
|
|
2014
Q4 | – | Sell |
-1,406
| Closed | -$32.4K | – | 2688 |
|
|
2014
Q3 | $32.4K | Buy |
+1,406
| New | +$32.4K | ﹤0.01% | 2403 |
|